.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
check out original content and videos published every day to help you learn about the issues that mean the most to you.
.
did you know? unleash the power of sip - invest in mutual funds
.